GDOC Among Gold ETFs
End-of-day Nov 18, 2026 · 40 Gold ETFs by YTD
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | −2.8% | +1.8% | +0.7% | +8.1% | +7.5% | +34.6% | — | — | −0.8% |
| Peer average | −1.2% | −5.3% | −6.8% | −11.2% | −1.8% | +2.6% | +83.2% | +68.8% | +190.4% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$145 of every $1,000 in GDOC is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 14.48% | $1,448.48 | 2,066 | $2.9M |
| 2 | JNJJohnson & Johnson | Healthcare | 6.28% | $627.79 | 4,548 | $1.3M |
| 3 | UNHUnitedhealth Group Incorporated | Healthcare | 5.62% | $562.03 | 2,912 | $1.1M |
| 4 | MRKMerck | Healthcare | 4.84% | $483.64 | 6,811 | $976K |
| 5 | EWEdwards Lifesciences | Healthcare | 4.83% | $482.70 | 9,244 | $975K |
| 6 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 4.00% | $399.78 | 1,511 | $807K |
| 7 | AAgilent Technologies | Healthcare | 3.83% | $382.56 | 4,485 | $772K |
| 8 | TMOThermo Fisher Scientific | Healthcare | 3.79% | $378.94 | 1,114 | $765K |
| 9 | AZN.LAstrazeneca ORD | Healthcare | 3.41% | $341.07 | 3,778 | $689K |
| 10 | DXCMDexcom | Healthcare | 3.38% | $337.95 | 8,317 | $682K |
| 11 | GILDGilead Sciences | Healthcare | 3.17% | $316.73 | 3,756 | $639K |
| 12 | GHGuardant Health | Healthcare | 3.13% | $313.03 | 4,411 | $632K |
| 13 | ABBVAbbvie | Healthcare | 3.05% | $304.71 | 2,101 | $615K |
| 14 | LONN.SWLonza Group AG | Healthcare | 3.02% | $301.74 | 771 | $609K |
| 15 | CORCencora | Healthcare | 2.81% | $281.10 | 1,619 | $568K |
of the $261B in 46 Gold ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.48% |
| 2 | JNJ | Johnson & Johnson | 6.28% |
| 3 | UNH | Unitedhealth Group Incorporated | 5.62% |
| 4 | MRK | Merck & | 4.84% |
| 5 | EW | Edwards Lifesciences | 4.83% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 4.00% |
| 7 | A | Agilent Technologies | 3.83% |
| 8 | TMO | Thermo Fisher Scientific | 3.79% |
| 9 | AZN.L | Astrazeneca ORD | 3.41% |
| 10 | DXCM | Dexcom | 3.38% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 23, 2025 | Dec 30, 2025 | $0.11 |
| Dec 23, 2024 | Dec 30, 2024 | $0.0058 |
| Dec 26, 2023 | Jan 2, 2024 | $0.18 |
| Sep 26, 2022 | Sep 30, 2022 | $0.0000 |